BioLineRx Ltd. (BLRX)
3.06
+0.20
(+6.99%)
USD |
NASDAQ |
May 22, 16:00
3.05
-0.01
(-0.33%)
After-Hours: 20:00
BioLineRx Shareholders Equity (Quarterly) : 18.20M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Compugen Ltd. | 95.35M |
| Pluri, Inc. | -18.60M |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 259.39M |
| Can-Fite BioPharma Ltd. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 40.90M |
| Total Liabilities (Quarterly) | 17.56M |
| Debt to Equity Ratio | 0.5578 |
| Current Ratio | 1.953 |
| Net Debt Paydown Yield | 32.30% |